ITP - IMMUNE THROMBOCYTOPENIA
Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to tame blood disorders
Disease control Recruiting nowThis early-stage trial tests a new drug called OM336 for people with autoimmune cytopenias, where the immune system attacks blood cells. The study includes 32 adults with conditions like immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA) who have not responded to…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Ouro Medicines • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug hope for teens with rare bleeding disorder
Disease control Recruiting nowThis study tests an IV medicine called efgartigimod in teens aged 12 to 18 who have had immune thrombocytopenia (ITP) for over a year. ITP causes low platelet counts, leading to bruising and bleeding. The goal is to find the right dose and see if it safely raises platelet levels.…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 08, 2026 12:00 UTC